-
3 Complex Generics and Oncology Company, Fermentation Ingredients Maker and Global Pharma Group Stocks With a Strong Future Roadmap: Natco Pharma, Concord Biotech and Lupin
- October 29, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
No Comments
Oncology, Fermentation and Global Pharma with a strong future roadmap: Natco Pharma, Concord Biotech and Lupin. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Complex Generics and Oncology Company, Active Ingredients Specialist and Contract Formulations Maker Stocks With a Strong Future Roadmap: Natco Pharma, Neuland Laboratories and Innova Captab
- October 28, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Oncology, Ingredient and Contract Pharma with a strong future roadmap: Natco Pharma, Neuland Laboratories and Innova Captab. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Complex Generics and Oncology Specialist, Global Generics Major and Cardiovascular and Gastro Brands Leader Stocks With a Strong Future Roadmap: Natco Pharma, Dr. Reddy’s Laboratories and Torrent Pharmaceuticals
- October 26, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Oncology, Global Generic and Heart Pharma Stocks with a strong future roadmap: Natco Pharma, Dr. Reddy’s Laboratories and Torrent Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Oncology Specialist, Respiratory and Global Generics Leader and Active Ingredients Maker Stocks With a Strong Future Roadmap: Natco Pharma, Cipla and Granules India
- October 26, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Oncology, Respiratory and API Pharma Stocks with a strong future roadmap: Natco Pharma, Cipla and Granules India. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.